DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 146 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q4 2020. The put-call ratio across all filers is 1.88 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $56,000 | +3.7% | 12,500 | 0.0% | 0.00% | – |
| Q3 2020 | $54,000 | -97.9% | 12,500 | -98.1% | 0.00% | -100.0% |
| Q4 2016 | $2,581,000 | -61.2% | 653,394 | +3.2% | 0.01% | -60.0% |
| Q3 2016 | $6,644,000 | +62.5% | 633,376 | +157.0% | 0.02% | +56.2% |
| Q2 2016 | $4,089,000 | +14.7% | 246,492 | +11.4% | 0.02% | 0.0% |
| Q1 2016 | $3,566,000 | -31.9% | 221,212 | +2.0% | 0.02% | -27.3% |
| Q4 2015 | $5,240,000 | +25.4% | 216,871 | +27.4% | 0.02% | +22.2% |
| Q3 2015 | $4,179,000 | – | 170,282 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8,415,000 | $105,945,000 | 12.42% |
| Chicago Capital, LLC | 5,842,906 | $73,562,000 | 4.06% |
| PFM Health Sciences, LP | 3,805,370 | $47,910,000 | 1.83% |
| Rhenman & Partners Asset Management AB | 800,000 | $10,072,000 | 1.14% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 2,320,000 | $29,209,000 | 0.71% |
| Rock Springs Capital Management LP | 1,681,458 | $21,170,000 | 0.62% |
| FEDERATED HERMES, INC. | 16,022,731 | $201,726,000 | 0.55% |
| FIRETHORN WEALTH PARTNERS, LLC | 47,376 | $665,000 | 0.54% |
| Jackson Creek Investment Advisors LLC | 82,435 | $1,185,000 | 0.48% |
| OBERWEIS ASSET MANAGEMENT INC/ | 137,200 | $1,727,000 | 0.44% |